1. Home
  2. CGNX vs RGEN Comparison

CGNX vs RGEN Comparison

Compare CGNX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cognex Corporation

CGNX

Cognex Corporation

N/A

Current Price

$61.26

Market Cap

10.2B

Sector

Industrials

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$172.17

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CGNX
RGEN
Founded
1981
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
10.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
CGNX
RGEN
Price
$61.26
$172.17
Analyst Decision
Buy
Buy
Analyst Count
20
22
Target Price
$79.11
★ $196.70
AVG Volume (30 Days)
★ 1.6M
1.1M
Earning Date
10-28-2026
10-27-2026
Dividend Yield
★ 0.56%
N/A
EPS Growth
9.68
★ 286.96
EPS
★ 0.74
0.24
Revenue
N/A
★ $141,236,000.00
Revenue This Year
$15.28
$12.02
Revenue Next Year
$10.99
$18.03
P/E Ratio
★ $82.31
$682.67
Revenue Growth
N/A
★ 35.10
52 Week Low
$34.60
$100.99
52 Week High
$72.88
$198.87

Technical Indicators

Market Signals
Indicator
CGNX
RGEN
Relative Strength Index (RSI) 50.25 46.87
Support Level $58.13 $159.22
Resistance Level $63.69 $175.32
Average True Range (ATR) 2.06 9.32
MACD 0.29 -2.80
Stochastic Oscillator 45.74 35.51

Price Performance

Historical Comparison
CGNX
RGEN

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: